Allogene's CEO David Chang to Depart Amid Industry Developments
In a significant shift for Allogene, CEO David Chang is stepping down. This news comes alongside Pfizer's major investment in Chinese pharmaceuticals and WHO's efforts in response to the Ebola outbreak.